Applied Dna Stock News

Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to COVID-19 testing. For Q4,

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stoc

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stoc

Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q4 2021 Results - Earnings Call Transcript

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tiling stocks: Applied DNA Sciences, Inc. (NASDAQ:APDN -4.15%), Morgan Stanley (NYSE:MS -0.66%) appeared first on Stocks Equity .

Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug Reata Pharmaceuticals, Inc.

Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2021-12-09. Here's what investors need to know before the announcement.

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative development. The sector r

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA to report fourth quarter and full-year 2021 financial results after market close on December 9, 2021.

Cannabis producer Flora Growth Corp. (NASDAQ: FLGC) announced on Monday that it has inked a licensing agreement with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded cannabis be

Cannabis producer Flora Growth Corp. (NASDAQ: FLGC ) announced on Monday that it has inked a licensing agreement with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded cannabis beverages across North America and Colombia under their renowned luxury lifestyle brand. Under the terms of the agreement, the Miami and Toronto-based company revealed that it will retain the right of first refusal to produce and distribute any CBD or CBG products globally under the Tonino Lamborghini brand. The products will be manufactured through Flora''s division, using Applied DNA Sciences, Inc. (NASDAQ: APDN ) molecular tagging and authentication technology to ensure product verification, in line with the new age of cannabis consumer packaged goods. The company will also retain Full story available on Benzinga.com

NEW YORK , Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, CODX, PRPO, XAIR, and CEMI. … Full story available on Benzinga.com